TAT and several other markers demonstrated an ability to predict the development of venous thromboembolism in patients with cervical cancer.

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.

The FDA reviews drug approval decisions that are expected in March 2025. The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

The FDA has issued a safety communication regarding the potential for missed alerts with diabetes devices due to software or hardware changes.

Patients that receive virtual cardiac rehabilitation have improved hospital admission and emergency department visit rates.

The majority of US adults use a device on a regular basis to monitor their heart health, but only 1 in 4 uses those data to have a conversation about their heart health with their doctor.

Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.

Federal agencies have removed web pages dedicated to DEI programs related to cancer research and other clinical research.

Prehospital measurement of glial fibrillary acidic protein (GFAP) can rapidly differentiate intracerebral hemorrhage (ICH) from ischemic stroke (IS) and stroke mimics.

Researchers, federal employees, and members of the public have voiced concerns about restrictions recently placed on federal health agencies.

Seropositive rheumatoid arthritis may be protective against the development of PAH, based on results of Mendelian randomization analyses.